Mesenchymal Stem Cells: Characteristics, Sources, and Mechanisms of Action

Veterinary Clinics of North America - Equine Practice

Volumn 27, Issue 2, 2011, Pages 243-261

  Stewart, Matthew C ^a   Stewart, Allison A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Chondrogenesis; Differentiation; Mesenchymal stem cell; Osteogenesis

Indexed keywords

ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELL; PHYSIOLOGY; REVIEW;

ANIMALS; CELL CULTURE TECHNIQUES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELLS;

EQUIDAE;

EID: 80052101258     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2011.06.004     Document Type: Review

References (140)

1. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
2. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
3. Yoo J.U., Barthel T.S., Mishimura K., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998, 80:1745-1757.
4. Murphy J.M., Dixon K., Beck S., et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002, 46:704-713.
5. Radcliffe C.H., Flaminio M.J., Fortier L.A. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Stem Cells Dev 2009, 19:269-282.
6. Bourzac C., Smith L.C., Vincent P., et al. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols. Equine Vet J 2010, 42:519-527.
7. Carrancio S., Lopez-Holgado N., Sanchez-Guijo F.M., et al. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 2008, 36:1014-1021.
8. Orford K.W., Scadden D.T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 2008, 9:115-128.
9. Kern S., Eichler H., Stoeve J., et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
10. Shirasawa S., Sekiya I., Sakaguchi Y., et al. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem 2006, 97:84-97.
11. Vidal M.A., Kilroy G.E., Lopez M.J., et al. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 2007, 36:613-622.
12. Mochizuki T., Muneta T., Sakaguchi Y., et al. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells. Arthritis Rheum 2006, 54:843-853.
13. Colleoni S., Bottani E., Tessaro I., et al. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Vet Res Commun 2009, 33:811-821.
14. Javazon E.H., Beggs K.J., Flake A.W. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004, 32:414-425.
15. Stolzing A., Coleman N., Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 2006, 9:31-35.
16. Rombouts W.J., Ploemacher R.E. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003, 17:160-170.
17. Tsutsumi S., Shimazu A., Miyazaki K., et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001, 288:413-419.
18. Zaragosi L., Ailhaud G., Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 2006, 24:2412-2419.
19. Bianchi G., Banfi A., Mastrogiacomo M., et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003, 287:98-105.
20. Solchaga L.A., Penick K., Porter J.D., et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005, 203:398-409.
21. Stewart A.A., Byron C.R., Pondenis H., et al. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res 2007, 68:941-945.
22. Grayson W.L., Zhao F., Bunnell B., et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007, 358:948-953.
23. Violini S., Ramelli P., Pisani L.F., et al. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol 2009, 10:29.
24. Park A., Hogan M.V., Kesturu G.S., et al. Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers. Tissue Eng Part A 2010, 16:2941-2951.
25. Halász K., Kassner A., Mörgelin M., et al. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007, 26:31168-31173.
26. Taylor S.E., Vaughan-Thomas A., Clements D.N., et al. Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems. BMC Musculoskelet Disord 2009, 10:27.
27. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
28. De Schauwer C., Meyer E., Van de Walle G.R., et al. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. Theriogenology 2010, 75:1431-1443.
29. Kolf C.M., Cho E., Tuan R.S. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007, 9:204.
30. Gronthos S., Zannettino A.C., Hay S.J., et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003, 116:1827-1835.
31. Hackett C.H., Flaminio M.J., Fortier L.A. Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow. Stem Cells Dev 2011, 20:721-735.
32. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
33. Haynesworth S.E., Baber M.A., Caplan A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992, 13:69-80.
34. Im G., Shin Y., Lee K. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?. Osteoarthritis Cartilage 2005, 13:845-853.
35. Djouad F., Bony C., Häupl T., et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 2005, 7:R1304-R1315.
36. Park J., Gelse K., Frank S., et al. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. J Gene Med 2006, 8:112-125.
37. Rebelatto C.K., Aguiar A.M., Moretao M.P., et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med 2008, 233:901-913.
38. Danišovic L., Varga I., Polak S., et al. Comparison of in vitro chondrogenic potential of human mesenchymal stem cells derived from bone marrow and adipose tissue. Gen Physiol Biophys 2009, 28:56-62.
39. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
40. Tumbar T., Guasch G., Greco V., et al. Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363.
41. Barker N., van Es J.H., Kuipers J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1008.
42. Kuang S., Kuroda K., Le Grand F., et al. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 2007, 129:999-1010.
43. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119:2204-2213.
44. Jones D.L., Wagers A.J. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 2008, 9:11-21.
45. Sacchetti B., Funari A., Michienzi S., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
46. Nöth U., Osyczka A.M., Tuli R., et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002, 20:1060-1069.
47. Sakaguchi Y., Sekiya I., Yagishita K., et al. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 2004, 104:2728-2735.
48. Zhu H., Guo Z., Jiang X., et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010, 5:550-560.
49. Suva D., Garavaglia G., Menetry J., et al. Non-hematopoietic human bone marrow contains long-lasting, pluripotent mesenchymal stem cells. J Cell Physiol 2004, 198:110-118.
50. Kopesky P.W., Lee H.Y., Vanderploeg E.J., et al. Adult equine bone marrow stromal cells produce a cartilage-like ECM mechanically superior to animal-matched adult chondrocytes. Matrix Biol 2010, 29:427-438.
51. Arnhold S.J., Goletz I., Klein H., et al. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res 2007, 231:1095-1105.
52. Kasashima Y., Ueno T., Tomita A., et al. Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells. Equine Vet J 2011, 43:288-294.
53. Schnabel L., Lynch M., van der Meulen M., et al. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 2009, 27(10):1392-1398.
54. Wilke M.M., Nydam D.V., Nixon A.J. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007, 25:913-925.
55. Frisbie D.D., Kisiday J.D., Kawcak C.E., et al. Evaluation of adipose derived stromal vascular fraction or bone marrow derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009, 27:1675-1680.
56. Smith R.K., Korda M., Blunn G.W., et al. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003, 35:99-102.
57. Pacini S., Spinabella S., Trombi L., et al. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007, 13:2949-2955.
58. Godwin E.E., Young N.J., Dudhia J., et al. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with over-strain injury of the superficial digital flexor tendon. Equine Vet J 2011, [Epub ahead of print]. 10.1111/j.2042-3306.2011.00363.x.
59. Ferris D.J., Frisbie D.D., Kisiday J.D., et al. Clinical follow-up of horses treated with bone marrow derived mesenchymal stem cells for musculoskeletal lesions. Proc AAEP Ann Conv 2009, 55:59.
60. Mambelli L.I., Santos E.J., Fraza P.J., et al. Characterization of equine adipose tissue-derived progenitor cells before and after cryopreservation. Tissue Eng Part C Methods 2009, 15:87-94.
61. da Silva Meirelles L., Sand T.T., Harman R.J., et al. MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A 2009, 15:221-229.
62. Estes B.T., Wu A.W., Guilak F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum 2006, 54:1222-1232.
63. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
64. Afizah H., Yang Z., Hui J.H., et al. A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng 2007, 13:659-666.
65. Huang J.I., Kazmi N., Durbhakula M.M., et al. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 2000, 5(23):1383-1389.
66. Sakaguchi Y., Sekiya I., Yagishita K., et al. Comparison of human stem cells derived from various mesenchymal tissues. Arthritis Rheum 2005, 52:2521-2529.
67. Toupadakis C.A., Wong A., Genetos D.C., et al. Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue. Am J Vet Res 2010, 71:1237-1245.
68. Kisiday J.D., Kopesky P.W., Evans C.H., et al. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008, 26:322-331.
69. Vidal M.A., Robinson S.O., Lopez M.J., et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 2008, 37:713-724.
70. Hennig T., Lorenz H., Thiel A., et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFβ receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 2007, 21:682-691.
71. Gonzalez-Rey E., Gonzalez M.A., Varela N., et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010, 69:241-248.
72. Bochev I., Elmadjian G., Kyurkchiev D., et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 2008, 32:384-393.
73. English A., Jones E.A., Corscadden D., et al. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology 2007, 46:1676-1683.
74. Petsa A., Gargani S., Felesakis A., et al. Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim 2009, 45:573-576.
75. Troyer D.L., Weiss M.L. Concise review: Wharton's Jelly-derived cells are a primitive stromal cell population. Stem Cells 2008, 26:591-599.
76. Barachini S., Trombi L., Danti S., et al. Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine. Stem Cells Dev 2009, 18:293-305.
77. Bi Y., Ehirchiou D., Kilts T.M., et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007, 13:1219-1227.
78. Stewart A.A., Barrett J.G., Byron C.R., et al. Comparison of equine tendon-, muscle-, and bone marrow-derived cells cultured on tendon matrix. Am J Vet Res 2009, 70:750-757.
79. Rui Y.F., Phil M., Lui P.P., et al. Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A 2010, 16:1549-1558.
80. Salingcarnboriboon R., Yoshitake H., Tsuji K., et al. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 2003, 287:289-300.
81. Yoshimura H., Muneta T., Nimura A., et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007, 327:449-462.
82. Nishimura K., Solchaga L.A., Caplan A.I., et al. Chondroprogenitor cells of synovial tissue. Arthritis Rheum 1999, 42:2631-2637.
83. Pei M., He F., Chen D., et al. Synovium-derived stem cell-based chondrogenesis. Differentiation 2008, 76:1044-1056.
84. Shintani N., Hunziker E.B. Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor β1 induce the formation of different types of cartilaginous tissue. Arthritis Rheum 2007, 56:1869-1879.
85. De Bari C., Dell'Accio F., Tylzanowski P., et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942.
86. Kurth T., Hedbom E., Shintani N., et al. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthritis Cartilage 2007, 15:1178-1189.
87. Arufe M.C., De la Fuente A., Fuentes-Boquete I., et al. Differentiation of Synovial CD-105{thorn} human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J Cell Biochem 2009, 108:145-155.
88. Ichinose S., Muneta T., Koga H., et al. Morphological differences during in vitro chondrogenesis of bone marrow-, synovium-MSCs, and chondrocytes. Lab Invest 2010, 90:210-221.
89. Dowthwaite G.P., Bishop J.C., Redman S.N., et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2003, 117:889-897.
90. Alsalameh S., Amin R., Gemba T., et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004, 50:1522-1532.
91. Koga H., Muneta T., Ju Y.J., et al. Synovial stem cells are regionally specified according to local microenvironments after implantation for cartilage regeneration. Stem Cells 2007, 25:689-696.
92. Chen Y., Kuykendall T.D., Caporali E., et al. Cells in equine synovial fluid exhibit chondrogenic capacity without evidence of an endochondral phenotype. Trans Orthop Res Soc 2009, 34:937.
93. Kuznetsov S.A., Mankani M.H., Gronthos S., et al. Circulating skeletal stem cells. J Cell Biol 2001, 153:1133-1139.
94. Kuznetsov S.A., Mankani M.H., Leet A.I., et al. Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells 2007, 25:1830-1839.
95. Tondreau T., Nathalie Meuleman N., Alain Delforge A. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005, 23:1105-1112.
96. Giovannini S., Brehm W., Mainil-Varlet P., et al. Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation 2008, 76:118-129.
97. Koerner J., Nesic D., Romero J.D., et al. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 2006, 24:1613-1619.
98. Ahern B.J., Schaer T.P., Shawn P., et al. Evaluation of equine peripheral blood apheresis product, bone marrow, and adipose tissue as sources of mesenchymal stem cells and their differentiation potential. Am J Vet Res 2011, 72:127-133.
99. Kasten P., Beyen I., Egermann M., et al. Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. Eur Cell Mater 2008, 16:47-55.
100. Nishimoto S., Oyama T., Matsuda K. Simultaneous concentration of platelets and marrow cells: a simple and useful technique to obtain source cells and growth factors for regenerative medicine. Wound Repair Regen 2007, 15:156-162.
101. Di Bella C., Barbara Dozza B., Frisoni T., et al. Injection of demineralized bone matrix with bone marrow concentrate improves healing in unicameral bone cyst. Clin Orthop Relat Res 2010, 468:3047-3055.
102. Jäger M., Herten M., Fochtmann U., et al. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2010, 29:173-180.
103. Hernigou P., Poignard A., Beaujean F., et al. Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005, 87:1430-1437.
104. Vadalá G., Di Martino A., Tirindelli M.C., et al. Use of autologous bone marrow cells concentrate enriched with platelet-rich fibrin on corticocancellous bone allograft for posterolateral multilevel cervical fusion. J Tissue Eng Regen Med 2008, 2:515-520.
105. Yoshioka T., Mishima H., Akaogi H., et al. Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop 2011, 35:823-829.
106. Fortier L.A., Potter H.G., Rickey E.J., et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am 2010, 92:1927-1937.
107. Chang F., Ishii T., Yanai T., et al. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res 2008, 26:18-26.
108. Crovace A., Lacitignola L., Rossi G., et al. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010, 2010:250978.
109. Varma M.J., Breuls R.G., Schouten T.E., et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev 2007, 16:91-104.
110. Nixon A.J., Dahlgren L.A., Haupt J.L., et al. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008, 69:928-937.
111. Vet-Stem Inc. Available at: Accessed July 14, 2011. http://vet-stem.com/equine/casestudies.php.
112. Caplan A.I. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 2005, 11:1198-1211.
113. Karlsson C., Brantsing C., Svensson T., et al. Differentiation of human mesenchymal stem cells and articular chondrocytes: analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J Orthop Res 2007, 25:152-163.
114. Mienaltowski M.J., Huang L., Frisbie D.D., et al. Transcriptional profiling differences for articular cartilage and repair tissue in equine joint surface lesions. BMC Med Genomics 2009, 2:60.
115. De Bari C., Dell'Accio F., Luyten F.P. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 2004, 50:142-150.
116. Stewart M.C., Saunders K.M., Burton-Wurster N., et al. Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, BMP-2 and serum supplementation. J Bone Miner Res 2000, 15:166-174.
117. Quintavallaa J., Uziel-Fusia S., Yin J., et al. Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials 2002, 23:109-119.
118. Guest D.J., Smith M.R., Allen W.R. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 2010, 42:636-642.
119. Murphy J.M., Fink D.J., Hunziker E.B., et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003, 48:3464-3474.
120. Hill C.E., Proschel C., Noble M., et al. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol 2004, 190:289-310.
121. Kuh S.U., Cho Y.E., Yoon D.H., et al. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 2005, 147:985-992.
122. Kuraitis D., Ruel M., Suuronen E.J. Mesenchymal stem cells for cardiovascular regeneration. Cardiovasc Drugs Ther 2011, 25(4):349-362.
123. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006, 98:1076-1084.
124. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996, 166:585-592.
125. Phinney D.G., Hill K., Michelson C., et al. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells 2006, 24:186-198.
126. Silva G.V., Litovsky S., Assad J.A., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111:150-156.
127. Tang J., Xie Q., Pan G., et al. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur J Cardiothorac Surg 2006, 30:353-361.
128. Sadat S., Gehmert S., Song Y.H., et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 2007, 363:674-679.
129. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005, 102:11474-11479.
130. Li Q., Turdi S., Thomas D.P., et al. Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction. Toxicol Lett 2010, 195:119-126.
131. Gnecchi M., He H., Noiseux N., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006, 20:661-669.
132. Shabbir A., Zisa D., Suzuki G., et al. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 2009, 296:H1888-H1897.
133. Li Y., Chen J., Zhang C., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49:407-417.
134. Harms K.M., Li L., Cunningham L.A. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1α-regulated VEGF signaling. PLoS One 2010, 5:e9767. 10.1371/journal.pone.0009767.
135. Syková E., Jendelová P., Urdzková L., et al. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol 2006, 26:1113-1129.
136. Wei X., Zhao L., Zhong J., et al. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett 2009, 462:76-79.
137. Lee R.H., Pulin A.A., Seo M.J., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
138. Ryan J.M., Barry F., Murphy J.M., et al. Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007, 149:353-363.
139. Shi Y., Hu G., Su J., et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010, 20:510-518.
140. Zheng Z.H., Li X.Y., Ding J., et al. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology 2008, 47:22-30.